← SynDRA
Nms-P715
SynDRA canonical compound SYN0060511 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | TTK |
|---|
| Mechanism of action | protein kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- TTK INHIBITOR
- protein kinase inhibitor
Cross-references
Synonyms
- RefChem:166202
- NMSP715
- GTPL9401
- orb1309330
- SCHEMBL1558596
- SCHEMBL29399449
- NMS-P715?
- C35H39F3N8O3
- JFOAJUGFHDCBJJ-UHFFFAOYSA-N
- GLXC-04418
- BDBM50349102
- MFCD19443684
- AKOS030526312
- CS-3396
- EBC-412043
- compound 15 [PMID: 21723120]
- NCGC00390549-01
- AC-30241
- HY-12382
- MS-31073
- F85064
- T12237
- BRD-K54170555-001-01-8
- N-(2,6-diethylphenyl)-1-methyl-8-({4-[(1-methylpiperidin-4-yl)carbamoyl]-2-(trifluoromethoxy)phenyl}amino)-4,5-dihydro-1H-pyrazolo[4,3-H]quinazoline-3-carboxamide
Look up Nms-P715 in the interactive SynDRA portal →